WallStreetZenWallStreetZen

NASDAQ: LMAT
Lemaitre Vascular Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LMAT past earnings growth

How has LMAT's earnings growth performed historically?
Company
44.68%
Industry
27.17%
Market
61.16%
LMAT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
LMAT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
LMAT's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

LMAT past revenue growth

How has LMAT's revenue growth performed historically?
Company
19.69%
Industry
7.75%
Market
16.96%
LMAT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LMAT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LMAT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LMAT earnings and revenue history

Current Revenue
$193.5M
Current Earnings
$30.1M
Current Profit Margin
15.6%
LMAT's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

LMAT Return on Equity

Current Company
10.5%
Current Industry
11.1%
Current Market
188%
LMAT's Return on Equity (10.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LMAT announces earnings.

LMAT Return on Assets

Current Company
9.1%
Current Industry
7.2%
LMAT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LMAT Return on Capital Employed

Current Company
12.46%
Current Industry
9.7%
LMAT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LMAT vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LMAT$193.48M$48.99M$30.11M+12.88%+2.88%
WRBY$669.77M-$30.55M-$63.20M+15.96%N/A
ATRC$399.25M-$8.11M-$30.44M+14.64%N/A
BLFS$143.27M-$51.75M-$66.43M+48.65%N/A
ATRI$169.33M$37.62M$19.41M+2.12%-9.83%
View Top Medical Stocks

LMAT earnings dates

Next earnings date
May 2, 2024

Lemaitre Vascular Earnings & Revenue FAQ

What were LMAT's earnings last quarter?

On Invalid Date, Lemaitre Vascular (NASDAQ: LMAT) reported Q4 2023 earnings per share (EPS) of $0.39, up 50% year over year. Total Lemaitre Vascular earnings for the quarter were $8.47 million. In the same quarter last year, Lemaitre Vascular's earnings per share (EPS) was $0.26.

If you're new to stock investing, here's how to buy Lemaitre Vascular stock.

What was LMAT's earnings growth in the past year?

As of Q2 2024, Lemaitre Vascular's earnings has grown 44.68% year over year. This is 17.51 percentage points higher than the US Medical Instruments & Supplies industry earnings growth rate of 27.17%. Lemaitre Vascular's earnings in the past year totalled $30.11 million.

What is LMAT's earnings date?

Lemaitre Vascular's earnings date is Invalid Date. Add LMAT to your watchlist to be reminded of LMAT's next earnings announcement.

What was LMAT's revenue last quarter?

On Invalid Date, Lemaitre Vascular (NASDAQ: LMAT) reported Q4 2023 revenue of $48.88 million up 19.36% year over year. In the same quarter last year, Lemaitre Vascular's revenue was $40.95 million.

What was LMAT's revenue growth in the past year?

As of Q2 2024, Lemaitre Vascular's revenue has grown 19.69% year over year. This is 11.94 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.75%. Lemaitre Vascular's revenue in the past year totalled $193.48 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.